Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 83-0847467 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To improve patient care through integration of Pharmacogenomics in drug development.
Total Revenue
$110K
FY2024
Total Expenses
$104K
FY2024
Net Assets
$268K
Program Ratio
83.9%
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.